Navigation Links
Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial
Date:6/8/2009

mation, please visit http://www.us.novartis.com.

References

  1. Thomas E. Witzig et al. A Phase II Trial of the Oral mTor Inhibitor Everolimus in Relapsed Non-Hodgkin's Lymphoma (NHL) and Hodgkin's Disease (HD). EHA 14th Congress. Berlin, Germany
  2. National Cancer Institute. General Information about Non-Hodgkin Lymphoma. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/adult-non-hodgkins/HealthProfessional/page2/print. Accessed May 21,2009
  3. National Cancer Institute. What You Need to Know About Non-Hodgkin's Lymphoma. What is Non-Hodgkin's Lymphoma? Available at: http://www.cancer.gov/cancertopics/wyntk/non-hodgkin-lymphoma. Accessed May 11,2009
  4. National Cancer Institute. General Information on Non-Hodgkin's. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/adult-nonhodgkins/HealthProfessional
  5. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Non-Hodgkin's Lymphoma. Available at: http://www.nccn.org/professionals/physician_gls/PDF/nhl.pdf. Accessed May 11, 2009
  6. X Zhang et al. Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning. BMC Cancer 2007, 7:235
  7. American Cancer Society. What Is Hodgkin's Disease? Available at: '/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Dec. 17, 2014  Beamz Interactive, Inc. (OTCQB: ... products, today announced that it has signed an ... and supplier of innovative prosthetic, orthotic and assistive ... of the agreement, RSL Steeper will promote and ... configured for use within UK residential care facilities ...
(Date:12/17/2014)... 17, 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... Trademark Office (USPTO) has issued a key patent ... immunotherapeutic vaccine targeting six tumor antigens that are ... Patent No. 8,871,211, which issued October 28, 2014, ... a dendritic cell composition comprising peptide epitopes of ...
(Date:12/17/2014)... Dec. 17, 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering, developing and commercializing innovative therapies addressing ... completion of enrollment in its first Phase 2a ... observations confirmed the 1-month findings that were reported ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , ...
Breaking Medicine Technology:Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
... 7 AT&T* and eCardio Diagnostics, one of ... announced the combination of mobile technology with cardiac ... heart patients. AT&T is providing eCardio with ... for near real-time, remote monitoring of cardiac patients. ...
... CVS Caremark (NYSE: CVS ) announced ... as Chief Operating Officer of its pharmacy benefit ... President, Rx Purchasing, Pricing and Network Relations, will ... mail service pharmacy and specialty pharmacy. ...
Cached Medicine Technology:AT&T and eCardio Diagnostics Team Up to Advance Cardiac Care Through Innovative Mobile Technology 2AT&T and eCardio Diagnostics Team Up to Advance Cardiac Care Through Innovative Mobile Technology 3CVS Caremark Appoints Jonathan C. Roberts as PBM Chief Operating Officer 2
(Date:12/19/2014)... 19, 2014 From November 24, 2014, ... for the year 2014 in its Goa retreat . ... Through the Indian winters, from November to March, Siddhi Yoga ... beach of Arambol, Goa. The Goa training sessions will conclude ... of yoga teacher training, the 10th intake is also a ...
(Date:12/19/2014)... This is a professional and in-depth study ... with a focus on the Chinese market. The report ... Gliquidone manufacturers and is a valuable source of guidance ... industry. , Firstly, the report provides a basic overview ... technology. Then, the report explores the international and Chinese ...
(Date:12/19/2014)... (HealthDay News) -- Being in good shape seems to reduce ... looked at data from more than 57,000 Americans, including more ... between 1991 and 2009. Those in the poorest shape ... blood pressure at the start of the study, compared to ... fitness. Of the more than 8,000 people diagnosed with ...
(Date:12/19/2014)... Amy Norton HealthDay Reporter ... born to moms who were exposed to high levels of ... of developing autism, a U.S. study suggests. Researchers found ... 1990 and 2002, those exposed to the most air pollution ... who later developed autism. And exposure during the third trimester, ...
(Date:12/19/2014)... (HealthDay News) -- Prostaglandin analogue eye drops -- a ... risk of vision loss in patients with the eye ... by David Garway-Heath, of the Moorfields Eye Hospital and ... more than 500 people newly diagnosed with open-angle glaucoma ... one of the leading causes of blindness. About ...
Breaking Medicine News(10 mins):Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 2Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 3Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 2Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 3Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 4Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 5Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 6Health News:Being Fit Keeps Blood Pressure in Check 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 3Health News:Study Supports Benefit of Widely Used Glaucoma Drug 2
... in China is smaller than that of many other countries, ... diabetics// of age between 20 and 79 in 2003. ... in China, while diabetics are mostly aged between 60 to ... Department in Beijing University People's Hospital. ,"Although no ...
... the Mecca of Fashion, Paris, have uncovered a mechanism ... natural chemical called opiorphin//, a natural pain alleviator, far ... their experiments, rodents were found to experience pain relief ... with the usual dosage of morphine. The finding which ...
... with incriminating evidence that warns non-vegetarians who binge on red ... out that eating more than one and a half servings ... breast cancer and another study that vitamin supplements seem ... diseases except for vitamin C which seems to show some ...
... fatty acid known as docosahexaenoic acid (DHA) in their ... dementia and Alzheimer’s disease, according to a study. ... been found to increase the risk of dementia and ... of cases of dementia in the elderly, according to ...
... Shelnutt and Yujiang Song from Sandia National Laboratories have ... attaches //to a cell which involves a new process that ... Security Administration laboratory. ,An upcoming issue of the German ... Angewandte Chemie Int. Ed which has currently published the same ...
... be just a matter of eating a salad a day. ... Americans will welcome a new study that could keep them ... study, conducted by the UCLA School of Public Health and ... revealed eating salads with salad dressing and raw vegetables is ...
Cached Medicine News:Health News:Red alert to women against red meat consumption 2Health News:Higher Level of Certain Fatty Acid Associated with Lower Dementia Risk 2Health News:Novel methods to view how a drug attaches to a cell 2Health News:A Salad a Day Keeps the Doctor Away This Winter 2
... RX600 is a versatile, fully powered orthopaedic ... built-in traction facilities, a powered centre break ... extremely versatile too. ,<br.,In fact the RX600 ... as it is for traction procedures. The ...
... For complete orthopedic trauma procedures. ... system, the orthopedic trauma table top ... for easy patient positioning and provides ... key trauma procedures: hip pinnings; femur, ...
... The EXOGEN 2000+ device provides a ... nonunion or the acceleration of fresh ... home for 20 minutes daily, or ... your physician determines your fracture to ...
... cannulated interference screws have a ... screw divergence. Screws are available ... lengths. Screws are supplied sterile, ... and 9mm dia. (screws are ...
Medicine Products: